Is FPRX A Good Stock To Buy Now?
Is Five Prime Therapeutics Inc (NASDAQ:FPRX) a good place to invest some of your money right now? We can gain invaluable insight to help us answer that question by studying the investment trends of top...
Five Prime Therapeutics Inc. (FPRX)
This company is not actively trading or the ticker does belong to another company in our database now.
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Olympiad Research LP Thong Nguyen | 0 | $0 | 0% | |
| 2. | Eversept Partners Kamran Moghtaderi | 0 | $0 | 0% | |
| 3. | Commodore Capital Egen Atkinson And Michael Kramarz | 0 | $0 | 0% | |
| 4. | Magnetar Capital Alec Litowitz And Ross Laser | 0 | $0 | 0% | |
| 5. | Alpine Associates Robert Emil Zoellner | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.98 | 2,334 | $11,632.66 | 583,912 | 2020-11-06 | Filing | |
| $4.88 | 15,355 | $74,996.89 | 581,578 | 2020-11-04 | Filing | |
| $4.98 | 10,436 | $52,013.02 | 3,434,990 | 2020-11-06 | Filing | |
| $4.88 | 143,403 | $700,408.93 | 3,424,554 | 2020-11-04 | Filing | |
| $4.98 | 17,230 | $85,874.32 | 4,611,909 | 2020-11-06 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $20.19 | 502,649 | $10,146,824.57 | 81,263 | 2020-11-11 | Filing | |
| $20.19 | 2,949,477 | $59,540,207.36 | 485,513 | 2020-11-11 | Filing | |
| $20.19 | 3,941,214 | $79,560,104.65 | 670,695 | 2020-11-11 | Filing | |
| $22.50 | 26,000 | $585,000.00 | 10,000 | 2020-11-11 | Filing | |
| $22.50 | 52,959 | $1,191,577.50 | 10,000 | 2020-11-11 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
Hedge Funds Are Coming Back To Five Prime Therapeutics Inc (FPRX)
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Is Five Prime Therapeutics Inc (FPRX) Going to Burn These Hedge Funds?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Is Five Prime Therapeutics Inc (FPRX) A Good Stock To Buy ?
Concerns over rising interest rates and expected further rate increases have hit several stocks hard during the fourth quarter of 2018.
Is Five Prime Therapeutics Inc (FPRX) A Good Stock To Buy?
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great stock picking abilities...
Cabiralizumab From Five Prime Therapeutics Inc (FPRX) Obtains Orphan Designation
The European Commission has certified orphan designation for cabiralizumab.
Bristol-Myers Squibb Co (BMY) Agrees To Extend Research With Five Prime Therapeutics Inc (FPRX)
Bristol-Myers Squibb Co (NYSE:BMY) has opted to extend the research term of its discovery collaboration agreement with Five Prime Therapeutics Inc (NASDAQ:FPRX).
Is Five Prime Therapeutics Inc (FPRX) A Good Stock To Buy?
It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment opportunity.
Why Do Hedge Funds Like Five Prime Therapeutics?
Five Prime Therapeutics Inc (NASDAQ:FPRX) is a $1.25 billion biotech company that focuses on the discovery and development of protein therapeutics that block cancer and inflammatory disease processes.
Battered Performance Sports Group Ltd (PSG) and Two Strong-Performing Companies Witness Insider Buying
According to fresh data from CNBC, the dollar value of all insider purchases in April has been the lowest in the past 11 months or so.
Hedge Fund Resource Center